Festa RA, Thiele DJ. Copper: an essential metal in biology. Curr Biol. 2011;21:R877–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7:378.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984;219:1–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kirshner JR, He S, Balasubramanyam V, Kepros J, Yang CY, et al. Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Cancer Ther. 2008;7:2319–27.

Article  CAS  PubMed  Google Scholar 

Oliveri V. Selective targeting of cancer cells by copper ionophores: an overview. Front Mol Biosci. 2022;9:841814.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng P, Zhou C, Lu L, Liu B, Ding Y. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Exp Clin Cancer Res. 2022;41:271.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22:102–13.

Article  CAS  PubMed  Google Scholar 

Finney L, Vogt S, Fukai T, Glesne D. Copper and angiogenesis: unravelling a relationship key to cancer progression. Clin Exp Pharmacol Physiol. 2009;36:88–94.

Article  CAS  PubMed  Google Scholar 

Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev. 2009;35:32–46.

Article  CAS  PubMed  Google Scholar 

Cobine PA, Brady DC. Cuproptosis: cellular and molecular mechanisms underlying copper-induced cell death. Mol Cell. 2022;82:1786–7.

Article  CAS  PubMed  Google Scholar 

Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer. 2023;22(1):46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Chen Y, Zhang J, Yang Y, Fleishman JS, Wang Y, et al. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updat. 2024;72:101018.

Article  CAS  PubMed  Google Scholar 

Lönnerdal B. Intestinal regulation of copper homeostasis: a developmental perspective. Am J Clin Nutr. 2008;88:846S-850S.

Article  PubMed  Google Scholar 

Wee NK, Weinstein DC, Fraser ST, Assinder SJ. The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease. Int J Biochem Cell Biol. 2013;45:960–3.

Article  CAS  PubMed  Google Scholar 

Knutson MD. Steap proteins: implications for iron and copper metabolism. Nutr Rev. 2007;65:335–40.

Article  PubMed  Google Scholar 

Wyman S, Simpson RJ, McKie AT, Sharp PA. Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro. FEBS Lett. 2008;582:1901–6.

Article  CAS  PubMed  Google Scholar 

La Fontaine S, Ackland ML, Mercer JF. Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: emerging roles. Int J Biochem Cell Biol. 2010;42:206–9.

Article  PubMed  Google Scholar 

Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev. 2007;87:1011–46.

Article  CAS  PubMed  Google Scholar 

Tsang T, Davis CI, Brady DC. Copper biology. Curr Biol. 2021;31:R421–7.

Article  CAS  PubMed  Google Scholar 

Polishchuk R, Lutsenko S. Golgi in copper homeostasis: a view from the membrane trafficking field. Histochem Cell Biol. 2013;140:285–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu N, Lo LS, Askary SH, Jones L, Kidane TZ, Trang T, et al. Transcuprein is a macroglobulin regulated by copper and iron availability. J Nutr Biochem. 2007;18:597–608.

Article  PubMed  PubMed Central  Google Scholar 

Moriya M, Ho YH, Grana A, Nguyen L, Alvarez A, Jamil R, et al. Copper is taken up efficiently from albumin and alpha2-macroglobulin by cultured human cells by more than one mechanism. Am J Physiol Cell Physiol. 2008;295:C708–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Freedman JH, Ciriolo MR, Peisach J. The role of glutathione in copper metabolism and toxicity. J Biol Chem. 1989;264:5598–605.

Article  CAS  PubMed  Google Scholar 

Hamza I, Prohaska J, Gitlin JD. Essential role for Atox1 in the copper-mediated intracellular trafficking of the Menkes ATPase. Proc Natl Acad Sci USA. 2003;100:1215–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garza NM, Swaminathan AB, Maremanda KP, Zulkifli M, Gohil VM. Mitochondrial copper in human genetic disorders. Trends Endocrinol Metab. 2023;34:21–33.

Article  CAS  PubMed  Google Scholar 

Boulet A, Vest KE, Maynard MK, Gammon MG, Russell AC, Mathews AT, et al. The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis. J Biol Chem. 2018;293:1887–96.

Article  CAS  PubMed  Google Scholar 

Cen D, Brayton D, Shahandeh B, Meyskens FL Jr, Farmer PJ. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J Med Chem. 2004;47:6914–20.

Article  CAS  PubMed  Google Scholar 

Tardito S, Bassanetti I, Bignardi C, Elviri L, Tegoni M, Mucchino C, et al. Copper binding agents acting as copper ionophores lead to caspase inhibition and paraptotic cell death in human cancer cells. J Am Chem Soc. 2011;133:6235–42.

Article  CAS  PubMed  Google Scholar 

Allensworth JL, Evans MK, Bertucci F, Aldrich AJ, Festa RA, Finetti P, et al. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer. Mol Oncol. 2015;9:1155–68.

Article  CAS  PubMed  PubMed Central